Healthcare firm Azenta jumps after quarterly results beat
** Shares of healthcare firm Azenta AZTA.O up 18% at $35.50 premarket ** Posts Q4 adjusted EPS of 21 cents vs estimates of 19 cents - data compiled by LSEG ** Quarterly revenue $159.2 million vs estimates of $156.2 million ** Expects fiscal 2026 total organic revenue growth of in range of 3% to 5% vs 3% increase in fiscal 2025 ** As of last close, stock down 40% YTD (Reporting by Koyena Das) ((Koyena.das@thomsonreuters.com))
Recent news on Azenta
See all newsUS RESEARCH ROUNDUP-Adobe, Domino's Pizza, Goldman Sachs
Brief: Azenta - Approves Restructuring Plan Within Multiomics Segment On October 5, 2026
Brooks Automation confidentially files for US IPO (updated)
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics
Azenta names interim CEO after Marotta resigns; shares fall